Radiomedix and Orano Med Announce the Initiation of the
Houston, TX and Plano, TX, Jan. 03, 2022 (GLOBE NEWSWIRE) -- RadioMedix and Orano Med are pleased to announce the initiation of the Phase II clinical trial of AlphaMedix™ with ...
Houston, TX and Plano, TX, Jan. 03, 2022 (GLOBE NEWSWIRE) -- RadioMedix and Orano Med are pleased to announce the initiation of the Phase II clinical trial of AlphaMedix™ with ...
PARIS--(BUSINESS WIRE)--Regulatory News: The Orano group today confirms the acquisition by Orano Nuclear Packages and Services (Orano NPS) of Daher group’s German nuclear activities – Daher Nuclear Technologies Gmbh (DNT) ...